We are joined by Devin Abrahami to discuss her poster session at the ADA 2019 annual meeting: Fracture risk in patients using sodium-glucose cotransporter 2 inhibitors: a real-world study.
Filmed at the American Diabetes Association (ADA) annual meeting 2019, San Francisco, USA.
Questions:
1. Why are patients with type 2 diabetes at enhanced risk of fractures? (0:05)
2. What are the effects of sodium-glucose cotransporter 2 inhibitors on bone metabolism? (1:28)
3. Could you tell us a little about the design and findings of your study? (2:31)
4. Which patient groups were at greatest risk of fracture? (3:54)
5. What were the limitations of your study and what future research is needed? (4:35)
Devin Abrahami has no conflicts of interest to declare in relation to this video.
touchENDO.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via free-to-access content in multimedia formats.
